The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. As of 2 May 2014 it had a market capitalisation of £79 billion, the fourth-largest of any company listed on the London Stock Exchange. It has a secondary listing on the New York Stock Exchange. Andrew Witty has been the chief executive offic...
Found on
http://en.wikipedia.org/wiki/GlaxoSmithKline
(from the article `Business Overview`) ...and Drug Administration (FDA) advisory panel voted in October to ban cough and cold medicines for children under six years of age, and another FDA ... ...Laboratories, took steps to acquire King Pharmaceuticals in a $4 billion deal that would enable Mylan to break into the branded-drug business....
Found on
http://www.britannica.com/eb/a-z/g/37
No exact match found.
